Kalvista Pharmaceuticals, Inc. · NASDAQ:KALV

Palleiko Benjamin L sold 1,129 Kalvista Pharmaceuticals, Inc. shares (Form 4)

Traded May 17 to May 18, 2026 · Filed May 19, 2026

From May 17 to May 18, 2026, Palleiko Benjamin L (Director, CHIEF EXECUTIVE OFFICER) sold 1,129 Kalvista Pharmaceuticals, Inc. shares at US$26.76 for US$30,212, leaving 467,665 shares. Filed May 19, 2026 (Form 4).

Sold
1,129 shares
Price
US$26.76
Value
US$30,212
Holding after
467,665 shares
Trading plan
No
Role
Director, CHIEF EXECUTIVE OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 17, 2026Common StockOption exercise2,419468,794Direct
May 18, 2026Common StockSale1,129US$26.76467,665Direct

Source

View original at SEC

Related